
ZOETERMEER, The Netherlands, November 2011 – Encouraged by field tests showing the efficiency of this new Iterative based reconstruction technology in clinical practice, Toshiba has decided that all new, and already installed, Aquilion ONE, Premium and PRIME scanners, should be entitled to this new technology. Without the need for substantial upgrade costs.
Clinical results show that AIDR 3D substantially reduces noise, while preserving sharp details, providing “natural looking” images. Reconstruction performed with AIDR 3D permits substantial dose reduction when compared to scans performed with traditional Filtered Back Projection (FBP) techniques. The AIDR 3D algorithm is designed to work in both the raw data and reconstruction domains and optimizes image quality for each particular body region.
As patients come in all shapes and sizes, automatic exposure control systems have proven to be very useful to maintain diagnostic image quality at a radiation dose suitable for each patient. It is therefore imperative that exposure control systems automatically react to dose reduction technology where made available to the customer. Toshiba’s SUREExposure 3D exposure control system is fully integrated into the imaging chain. With the integration of AIDR 3D in the scan protocol, the exposure is automatically reduced by up to 75% while assuring the best diagnostic image quality at the lowest dose for all patients.
Clinical experience in CHU Nancy, France
When Toshiba installed AIDR 3D, our staff initially looked critically at the image quality for all type of scans. We may say that we are very happy with the Image Quality and surprised by the low dose levels. Follow-up studies, when compared to previous scans, already clearly demonstrated the impact of AIDR 3D” says Prof. Alain Blum-Moyse, Head of Radiology CHU Nancy, France.
“Noise is reduced dramatically. However this new technology is especially good in artifact suppression (streaks, beam-hardening, etc.). With AIDR 3D integrated in the SUREExposure 3D we were able to achieve a dose reduction by up to 75% by the same Standard Deviation (SD) for noise. But we found in some studies, with the same SD the image quality was so good, we could increase the SD even further, resulting in an even higher average dose reduction!! We are very enthusiastic with AIDR 3D, a very promising application is chest CT-scan with ultra low dose, I don’t think we will miss any nodule or lymph node with these scans.”
Key features of AIDR 3D
• Full integration in scan protocols for improved workflow
• Dose reduction in clinical setting by up to 75%
• Minimal penalty in reconstruction times
• Noise reduction and improved Spatial Resolution

AIDR 3D (right) was applied to low dose kidney perfusion protocol: 100 kV, 25 mA
(Images courtesy of Keio University, Japan.)
====== END ======
Aquilion, Aquilion ONE and SUREExposure are trademarks of Toshiba Medical Systems Corporation.
About Toshiba Medical Systems Europe BV
With headquarters in Zoetermeer, The Netherlands, Toshiba Medical Systems Europe BV markets, sells, distributes and services diagnostic imaging systems, and coordinates clinical diagnostic imaging research for all modalities in Europe.
For more information, visit www.toshiba-medical.eu
About Toshiba Medical Systems Corporation
Toshiba Medical Systems Corporation is a leading worldwide provider of medical diagnostic imaging systems and comprehensive medical solutions, such as CT, X-ray and vascular, ultrasound, nuclear medicine, and MRI systems, as well as information systems for medical institutions. Toshiba Medical Systems Corporation has been providing medical products for over 80 years. In October 2003, Toshiba Medical Systems Corporation, which prior to that time had been operating as the Medical Systems Division of Toshiba Corporation (“Toshiba”), was established as a stand-alone member of the Toshiba group. Toshiba Medical Systems Corporation is a wholly-owned subsidiary of Toshiba.
For more information, visit http://www.toshiba-medical.co.jp/tmd/english
About Toshiba Corporate
Toshiba is a diversified manufacturer and marketer of advanced electronic and electrical products, spanning digital products, such as LCD TVs, notebook PCs and hard disc drives; electronic devices and components, such as semiconductors; social infrastructure systems, including power generation systems, and home appliances. Toshiba was founded in 1875, and today operates a global network of more than 490 companies, with 203,000 employees worldwide and annual sales surpassing 6.3 trillion yen (US$77 billion).
For more information, visit www.toshiba.co.jp/index.htm
For further information:
Contact: Henk Zomer, Sr. Business Unit Manager CT
E-mail: hzomer@tmse.nl
Contact: Jack Hoogendoorn, Sr. Manager Marketing Communications
E-mail: jhoogendoorn@tmse.nl